Leukemia Research
Volume 26, Issue 3 , Pages 289-295, March 2002

CD56+, NKp46+ cell line (MZ93) expressing T-cell and myeloid antigens

  • Shigeo Hashimoto

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Ken Toba

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-25-227-2185; fax: +81-25-227-0774
  • ,
  • Junjiro Tsuchiyama

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Takashi Abe

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Toshio Yano

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Akihito Momoi

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Kiyoshi Okazuka

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Naoko Kanazawa

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan
  • ,
  • Masuhiro Takahashi

      Affiliations

    • School of Health Sciences, Faculty of Medicine, Niigata University, Niigata City 951-8510, Japan
  • ,
  • Yoshifusa Aizawa

      Affiliations

    • First Department of Internal Medicine, School of Medicine, Niigata University, Asahimachi-dori 1, Niigata City 951-8520, Japan

Received 12 February 2001; accepted 17 May 2001.

Abstract 

The MZ93 cell line, established from a patient with CML, expressed CD4, CD7, CD13, CD25, CD33, CD34, CD56 and NKp46. The additional karyotype abnormality of the Ph-positive leukemia cells in vivo, 6p+, was also observed in MZ93. The early passages of MZ93 expressed CD3 in the cytoplasm, but the late passages did not. The cells did not express mature NK-markers as expected. The messenger RNAs of CD2 and NKp46 were detected and those of CD3ε and CD3ζ were absent in the cells. Therefore, the cell line has the immunophenotype likely to NK and/or T cell precursor.

Keywords:  T/NK cell precursor acute leukemia, Cell line, MZ93, CD56, NKp46, Chronic myelogeneous leukemia

Abbreviations:  AML, acute myelogeneous leukemia, CML, chronic myelogeneous leukemia, FITC, fluorescein isothiocyanate, GPA, glycophorin A, MPO, myeloperoxidase, NK, natural killer, PCR, polymerase chain reaction, PE, phycoerythrin, Ph, Philadelphia, PPO, platelet peroxidase, RT-PCR, reverse transcriptase polymerase chain reaction, TCR, T cell receptor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(01)00115-1

Leukemia Research
Volume 26, Issue 3 , Pages 289-295, March 2002